pimagedine has been researched along with Day Blindness in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Perindopril treatment produced improvements (p<0." | 1.32 | ACE inhibition salvages the visual loss caused by diabetes. ( Armitage, JA; Bui, BV; Cooper, ME; Tolcos, M; Vingrys, AJ, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bui, BV | 1 |
| Armitage, JA | 1 |
| Tolcos, M | 1 |
| Cooper, ME | 1 |
| Vingrys, AJ | 1 |
1 other study available for pimagedine and Day Blindness
| Article | Year |
|---|---|
ACE inhibition salvages the visual loss caused by diabetes.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diab | 2003 |